Literature DB >> 2478851

Immunological study of dystrophin in Duchenne fetus.

I B Ginjaar, E Bakker, J T den Dunnen, M M van Paassen, G J van Ommen, E Zubrzycka-Gaarn, M D Kloosterman, A Wessels, A F Moorman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2478851     DOI： 10.1016/s0140-6736(89)91813-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections.

Authors:  T M Nguyen; I B Ginjaar; G J van Ommen; G E Morris
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane.

Authors:  T R Helliwell; J M Ellis; R C Mountford; R E Appleton; G E Morris
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

3.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Immunohistochemical studies show truncated dystrophins in the myotubes of three fetuses at risk for Duchenne muscular dystrophy.

Authors:  I B Ginjaar; E Bakker; M M van Paassen; J T den Dunnen; A Wessels; E E Zubrzycka-Gaarn; A F Moorman; G J van Ommen
Journal:  J Med Genet       Date:  1991-08       Impact factor: 6.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.